Immunotherapy for melanoma in Germany            
According to MDPI clinical data, melanoma accounts for 1.7% of global cancer diagnoses and is the fifth most common cancer in the US. Melanoma incidence is rising in developed, predominantly fair-skinned countries, growing over 320% in the US since 1975. That is why it is very important to look for new effective treatments, one of...
                                            Diagnostics of lung cancer            
With 2.5 million new cases in 2022 and 1.8 million deaths, lung cancer remains the most common cancer diagnosed worldwide. The challenge is early detection: only 17% and 15% of lung cancers in women and men, respectively, are diagnosed at stage 1, when survival is 80-93%. Those with advanced lung cancer have survival rates of less than 20%.
                                            Stem Cell Treatment for Erectile Dysfunction in Germany            
Erectile dysfunction (ED) is a disease in which it is impossible to achieve a sufficient erection for sexual intercourse. This pathology can have many reasons. Depending on the origin, erectile dysfunction requires different approaches to treatment. Studies in Germany show ED prevalence rates between 18% and 48% among...
                                            Breast Cancer Treatment in Germany            
Breast cancer is the most commonly diagnosed cancer worldwide, with 2.3 million new cases and nearly 670,000 deaths reported in 2022. According to the World Health Organization, the global burden is expected to rise by almost 40% by 2050, reaching over 3.2 million new cases annually. Women in high-income countries have about a 1 in 12...
                                            Immunotherapy for colon cancer in Germany            
Colorectal cancer (CRC) is a significant public health concern in Germany, ranking among the most commonly diagnosed cancers. In 2022, approximately 24,650 women and 29,960 men were newly diagnosed with CRC. The incidence rates are notably higher in individuals over the age of 55, with the majority of cases originating in the colon...
                                            Alternative treatments of oncological diseases in Germany            
Cancer remains far too common across Europe. In 2022 alone, there were approximately 4.47 million new cancer diagnoses - that's nearly one in four people up to age 75 developing cancer in their lifetime. This scale of disease highlights why blending integrative oncology with robust, conventional cancer care has become essential...
                                            Brachytherapy for Uterine Cancer            
Uterine cancer, and particularly endometrial cancer - the most common form - has become an increasingly urgent concern worldwide. According to a recent PubMed-indexed global burden analysis, there were approximately 360,253 new cases and 84,630 deaths from endometrial cancer among postmenopausal women in 2021. These figures...
                                            Brain tumor symptoms            
Globally, brain and central nervous system (CNS) cancers are a significant health burden. In 2022, there were approximately 321,600 new cases and 248,400 deaths from brain and CNS cancers worldwide – a mortality-to-incidence ratio nearing 78% in adults ≥15 years old. Meanwhile, research shows that global deaths from these cancers...
